Aaron de Mello

Aaron De Mello is a seasoned business development professional with extensive experience in the clinical research and pharmaceutical sectors. Currently serving as Senior Director of Business Development at AIXIAL GROUP, Aaron is focused on developing therapies for oncology, cell & gene, and rare diseases. Previous roles include Senior Director of Business Development at Allucent and Associate Key Account Director at IQVIA, where leadership was key in managing real-world offerings for pharmaceutical clients in the NEMEA region. Aaron’s career also features significant positions at PAREXEL, Covance, SynteractHCR, Richmond Pharmacology, CPRS Group, ProClinical, and Barrington James, illustrating a consistent trajectory of increasing responsibility in business development and consultancy. Aaron holds a degree from Solent University and completed early education at Kent College, Canterbury.